Xcelience

Continues Growth Despite Challenging Economy

Xcelience, a leader in early drug development services, has developed a faster, more cost effective path to Phase I studies using Xcelodose® 600/600 S precision powder micro-dosing systems (Xcelodose® is a registered trademark of Capsugel® BVBA).